Butisol Sodium (Meda Pharmaceuticals)


Welcome to the PulseAid listing for the Butisol Sodium drug offered from Meda Pharmaceuticals. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Meda Pharmaceuticals
NON-PROPRIETARY NAME: Butabarbital Sodium
SUBSTANCE NAME: BUTABARBITAL SODIUM
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1939-08-01
END MARKETING DATE: 0000-00-00


Butisol Sodium HUMAN PRESCRIPTION DRUG Details:

Item DescriptionButisol Sodium from Meda Pharmaceuticals
LABELER NAME: Meda Pharmaceuticals
DEA SCHEDULE: CIII
ACTIVE STRENGTH: 30(mg/1)
START MARKETING DATE: 1939-08-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0037-0113_96204987-d16c-47c1-b424-b94c13e347b7
PRODUCT NDC: 0037-0113
APPLICATION NUMBER: NDA000793

Other BUTABARBITAL SODIUM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Meda PharmaceuticalsButisol Sodium